- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03864016
Ability of Pupillometry to Reduce Sufentanil Consumption in Planned Cardiac Surgery: Randomized, Controlled, Single-center Clinical Superiority Trial (PUCCAR)
The objective of general anesthesia is to obtain a loss of consciousness, stillness, and sufficient analgesia to allow surgery. Thus, general anesthesia has two components: hypnosis and analgesia. Combining these two components, with parallel use of a hypnotic agent and a morphine agent makes major surgery possible by limiting the stress on the body. In clinical practice, hypnosis can be assessed by a monitor of the depth of BIS®-type anesthesia, based on a simplified measurement of the patient's spontaneous cortical electroencephalographic activity. However, BIS® type monitors do not specifically judge analgesia.
Traditionally, analgesia is assessed on the basis of hemodynamic changes (blood pressure, heart rate) in relation to a nociceptive stimulus. There is an interaction between pain and cardiovascular control that is mediated by the baroreflex system. But not all hemodynamic changes during general anesthesia are necessarily secondary to nociceptive stimulation. For example, hypovolemia may be responsible for tachycardia without causing pain; opening the pericardium during cardiac surgery may increase blood pressure by increasing cardiac output.... On the other hand, a decrease in hemodynamic response can be observed in relation to the depressant effect of anesthetic agents, despite a lack of analgesia. Similarly, patients' disease-modifying treatments may mask hemodynamic responses (e.g. beta blocker). Thus, the appearance of tachycardia or high blood pressure during surgery does not necessarily reflect a nociceptive process. Currently, the available data do not allow the anaesthetist to differentiate between real hemodynamic changes related to nociception and sympathicotonia. This leads to typical management consisting of an increase in the dosage of morphine.
Pupillometry (monitoring the pupillary dilation reflex) is a simple and sensitive clinical approach that can be done during general anesthesia to specifically monitor the nociceptive component. The main objective of monitoring is to achieve a more rational use of opioids. This means optimizing opioid dosing, ensuring safety by monitoring the lowering of opioid dosages intraoperatively without the risk of waking up, and reducing postoperative hyperalgesia. In the context of cardiac surgery, the interpretation of hemodynamic changes could be facilitated by nociception monitoring coupled with anesthesia monitoring (BIS). Reducing opiod doses without changing other clinical parameters could ensure better hemodynamic stability in increasingly fragile patients.
Studieöversikt
Status
Betingelser
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
-
Dijon, Frankrike, 2100
- CHU Dijon Bourgogne
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Person who has given written consent
- Adult patient
- Patient undergoing coronary artery bypass surgery with CEC, with or without valve surgery, by sternotomy.
- ASA <4.
Exclusion Criteria:
- Person not affiliated to the national health insurance system
- Person subject to legal protection (curatorship, guardianship)
- Person who has been deemed mentally incompetent
- Pregnant, parturient or breastfeeding woman
- Adult unable or unwilling to provide consent
- Patient with preoperative cognitive dysfunction (MMS <13) (APPENDIX 6),
- Patient with morphine intolerance,
- Patient on long-term opioid treatment,
- Emergency surgery,
- Eye disease, corneal injury, or wearing contact lenses, a neurological disease that can influence the pupillary reflex,
- Refusal to participate
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Övrig
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Övrig: Standard group
|
The hypnotic agent used is Propofol and the morphine agent used is Sufentanil.
At induction the target concentration of sufentanil is 0.5 ng/ml.
The sufentanil dose is decided by the anaesthetist, taking into account the operating times (induction, TIO, incision, opening and sternal spacing, CEC, closure), the usual data provided by the monitoring: heart rate, blood pressure, BIS, EtCO2, modification of insufflation pressures.
|
Experimentell: Pupillometry group
|
The hypnotic agent used is Propofol and the morphine agent used is Sufentanil.
At induction, the target concentration of sufentanil is 0.5 ng/ml.
The dose of sufentanil is then adjusted according to the dilation reflex obtained with the PPI (Pain Pupillary Index) at predefined times.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Total dose of sufentanil required per operation
Tidsram: Through study completion an average of 2 years
|
Total dose of sufentanil expressed in µg
|
Through study completion an average of 2 years
|
Samarbetspartners och utredare
Publikationer och användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- BERTHOUD 2018
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Patienter som genomgår hjärtkirurgi
-
Medistim ASAHar inte rekryterat ännuCardiac Bypass Surgery (CABG)
Kliniska prövningar på Induction and maintenance of anesthesia
-
Microclinic InternationalHarvard School of Public Health (HSPH); Qatar University; Qatar Foundation; Qatar Diabetes Association och andra samarbetspartnersAvslutadHypertoni | Övervikt och fetma | Diabetes mellitus, typ II | Beteende livsstilsförändring | Social förändringQatar
-
University Hospital, Clermont-FerrandOkänd
-
Mostafa BahaaMostafa Mahmoud Bahaa Clinical Pharmacy Department, Horus University,...Har inte rekryterat ännuPsykiatrisk störning
-
Assuta Hospital SystemsAvslutad
-
Children's Hospital Medical Center, CincinnatiAvslutadAttention Deficit Hyperactivity DisorderFörenta staterna
-
Abramson Cancer Center at Penn MedicineGilead SciencesRekryteringBröstcancer | Sociala bestämningsfaktorer för hälsa (SDOH)Förenta staterna
-
Memorial Sloan Kettering Cancer CenterAvslutadAscitesFörenta staterna
-
Karolinska InstitutetAvslutadStroke | Afasi | Talets apraxiSverige
-
Sohag UniversityHar inte rekryterat ännuTic Disorder, barndomEgypten
-
University of New HampshireNational Institute on Alcohol Abuse and Alcoholism (NIAAA); University... och andra samarbetspartnersAvslutadDepression | Alkohol dricka | Alkohol; Skadlig användning | Sociala färdigheter | Coping Beteende | Posttraumatisk stressyndrom | Coping färdigheter | Socialt beteende | Alkoholmissbruk | Dricker, College | Socialt stigma | Empati | Självkritik | Sociala normer | Socialt ansvarFörenta staterna